Marks Gilbert Lynn 4
4 · AN2 Therapeutics, Inc. · Filed Apr 11, 2025
Insider Transaction Report
Form 4
Marks Gilbert Lynn
Director
Transactions
- Award
Common Stock
2025-04-10+9,705→ 41,507 total
Footnotes (1)
- [F1]Represents shares issued in lieu of cash compensation under the issuer's non-employee director compensation policy. All shares vest immediately.